Drug
Zp6590
Zp6590: highest development phase Phase 1, developed by Zealand Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP6590, solution for injection NCT07721597 | Phase 1 | Healthy Participants Study |
Latest
No recent events.
Follow Zp6590 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.